| Thomas E Lawlor, MD | |
|
263 Farmington Ave, Psychiatry, Farmington, CT 06030-0001 | |
| (860) 679-6700 | |
| (860) 679-6736 |
| Full Name | Thomas E Lawlor |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 42 Years |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780680702 | NPI | - | NPPES |
| 1359729 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 035972 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Dempsey Hospital | Farmington, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Connecticut Health Center | 3678472016 | 523 |
| State Of Connecticut | 8022915677 | 194 |
News Archive
Dr Katherine Payne has been announced the winner of the Pharmacy Practice Research Trust 2010 Royal Pharmaceutical Society (RPS)Conference Practice Research Award. The award will be presented at the conference on Monday, 6th September when Dr Payne will deliver a plenary lecture on her prize-winning research.
This study proposes a mathematical framework to analyze the effect of the viruses on type I interferon (IFN-I) signaling, which is part of the innate immune response. IFN-I brings about natural killer cell activation, which in turn causes the activation of macrophages.
Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine reports that inhibition of a key enzyme safely and effectively improved the health of persons with non-alcoholic fatty liver disease, a chronic metabolic disorder that affects hundreds of millions of people worldwide.
A family history of obesity, high blood pressure, high blood lipid levels, type 2 diabetes and coronary heart disease should all be considered high risk factors for the early onset and severity of obesity in children, reveals a new study.
› Verified 5 days ago
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
Dr Katherine Payne has been announced the winner of the Pharmacy Practice Research Trust 2010 Royal Pharmaceutical Society (RPS)Conference Practice Research Award. The award will be presented at the conference on Monday, 6th September when Dr Payne will deliver a plenary lecture on her prize-winning research.
This study proposes a mathematical framework to analyze the effect of the viruses on type I interferon (IFN-I) signaling, which is part of the innate immune response. IFN-I brings about natural killer cell activation, which in turn causes the activation of macrophages.
Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine reports that inhibition of a key enzyme safely and effectively improved the health of persons with non-alcoholic fatty liver disease, a chronic metabolic disorder that affects hundreds of millions of people worldwide.
A family history of obesity, high blood pressure, high blood lipid levels, type 2 diabetes and coronary heart disease should all be considered high risk factors for the early onset and severity of obesity in children, reveals a new study.
› Verified 5 days ago
| Entity Name | State Of Connecticut |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669466561 PECOS PAC ID: 8022915677 Enrollment ID: O20041122000596 |
News Archive
Dr Katherine Payne has been announced the winner of the Pharmacy Practice Research Trust 2010 Royal Pharmaceutical Society (RPS)Conference Practice Research Award. The award will be presented at the conference on Monday, 6th September when Dr Payne will deliver a plenary lecture on her prize-winning research.
This study proposes a mathematical framework to analyze the effect of the viruses on type I interferon (IFN-I) signaling, which is part of the innate immune response. IFN-I brings about natural killer cell activation, which in turn causes the activation of macrophages.
Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine reports that inhibition of a key enzyme safely and effectively improved the health of persons with non-alcoholic fatty liver disease, a chronic metabolic disorder that affects hundreds of millions of people worldwide.
A family history of obesity, high blood pressure, high blood lipid levels, type 2 diabetes and coronary heart disease should all be considered high risk factors for the early onset and severity of obesity in children, reveals a new study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas E Lawlor, MD 263 Farmington Ave, Provider Enrollment Office, Farmington, CT 06030-2212 Ph: (860) 679-7503 | Thomas E Lawlor, MD 263 Farmington Ave, Psychiatry, Farmington, CT 06030-0001 Ph: (860) 679-6700 |
News Archive
Dr Katherine Payne has been announced the winner of the Pharmacy Practice Research Trust 2010 Royal Pharmaceutical Society (RPS)Conference Practice Research Award. The award will be presented at the conference on Monday, 6th September when Dr Payne will deliver a plenary lecture on her prize-winning research.
This study proposes a mathematical framework to analyze the effect of the viruses on type I interferon (IFN-I) signaling, which is part of the innate immune response. IFN-I brings about natural killer cell activation, which in turn causes the activation of macrophages.
Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine reports that inhibition of a key enzyme safely and effectively improved the health of persons with non-alcoholic fatty liver disease, a chronic metabolic disorder that affects hundreds of millions of people worldwide.
A family history of obesity, high blood pressure, high blood lipid levels, type 2 diabetes and coronary heart disease should all be considered high risk factors for the early onset and severity of obesity in children, reveals a new study.
› Verified 5 days ago
William P Shea Iii, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Kristina Frances Victoria Zdanys, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Psychiatry, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Marie Carl Eugene, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Neurology Mc-3835, Farmington, CT 06030 Phone: 860-679-4888 Fax: 860-679-1042 | |
Kelly Nicole Stinson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10 Talcott Notch Rd, Farmington, CT 06032 Phone: 860-679-6700 Fax: 860-679-6736 | |
Feier Liu, D.O Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Gema Guanco, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 270 Farmington Ave, Suite 309, Farmington, CT 06032 Phone: 860-677-5570 Fax: 860-677-9570 | |
Dr. Asante Kofi Mendes, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2000 |